Prosecution Insights
Last updated: May 29, 2026

Medlen & Carroll, LLP

15 pending office actions • 8 clients • 14 examiners • 14 art units • 0 of 15 (0%) have an AI response strategy ready • 18 patents granted in the last 365 days

Portfolio Summary

15
Total Pending OAs
10
Non-Final OAs
5
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 15 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

9
Overdue
0
Due this week
2
Due this month
3
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 15 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (9)Due ≤ 30 days (2)Due ≤ 60 days (3)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
10
Medium (67%)
4
Easy (27%)
1
Unknown (7%)

Rejection Statute Mix

BucketCases
§103 only9 (60%)
§102 only1 (7%)
§112 only4 (27%)
No statute on record1 (7%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

12
Life Sciences
80% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
7% of docket
2
Mechanical / Eng
13% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

150 h
Manual time on pending OAs
30 h
Time saved (low, 20%)
52 h
Time saved (mid, 35%)
1.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ICET, DANIEL ALLEN 2 51.2% +53.9%
LEONARD, ARTHUR S 1 50.5% +50.7%
BOWMAN, ANDREW J 1 65.7% +12.9%
XU, XIAOYUN 1 59.6% +32.3%
AFREMOVA, VERA 1 50.6% +29.2%
NICOL, ALEXANDER W 1 42.0% +44.9%
SINES, BRIAN J 1 80.4% +4.6%
CHEU, CHANGHWA J 1 74.6% +47.4%
KIDWELL, KAITLYN ELIZABETH 1 81.4% +25.4%
KONOPKA, CATHERINE ANNE 1 58.8% +63.7%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18027834 CONTINUOUS INFRARED SPECTROSCOPY SYSTEM AND METHOD KIDWELL, KAITLYN ELIZABETH 2d overdue
18520821 CONTROLLING PRESSURE SINES, BRIAN J 55d

Interview Candidates (10)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18980456 Targeted CRISPR Delivery Platforms LEONARD, ARTHUR S 50d overdue
18199195 SCAFFOLD LOADING AND DELIVERY SYSTEMS ICET, DANIEL ALLEN 19d overdue
17921027 IMPROVED CAS 12A/NLS MEDIATED THERAPEUTIC GENE EDITING PLATFORMS KONOPKA, CATHERINE ANNE 16d overdue
18591819 HOST-BIOME INTERACTIONS AFREMOVA, VERA 4d overdue
18027834 CONTINUOUS INFRARED SPECTROSCOPY SYSTEM AND METHOD KIDWELL, KAITLYN ELIZABETH 2d overdue
17113516 Scaffold Loading and Delivery Systems ICET, DANIEL ALLEN 12d
18500793 GLOBAL PROTEOMIC SCREENING OF RANDOM BEAD ARRAYS USING MASS SPECTROMETRY IMAGING CHEU, CHANGHWA J 29d
18566367 CAS9 NICKASE-MEDIATED GENE EDITING NICOL, ALEXANDER W 34d

Client Portfolio (8 clients)

Top Art Units

Art UnitApps
37712
16311
17171
17971
16531
16341
17961
16781
28771
16351

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
18980456 Targeted CRISPR Delivery Platforms UNIVERSITY OF MASSACHUSETTS LEONARD, ARTHUR S 1631 Other Final Rejection 50d overdue Pending Dec 13, 2024
18810072 IMPLANTABLE SCAFFOLDS FOR TREATMENT OF SINUSITIS Lyra Therapeutics, Inc. BOWMAN, ANDREW J 1717 §103 Non-Final OA 72d Pending Aug 20, 2024
18678276 Novel Photocleavable Mass-Tags for Multiplexed Mass Spectrometric Imaging of Tissues Using Biomolecular Probes AmberGen, Inc. XU, XIAOYUN 1797 §112 Non-Final OA 41d Pending May 30, 2024
18591819 HOST-BIOME INTERACTIONS Emulate, Inc. AFREMOVA, VERA 1653 §102 Non-Final OA 4d overdue Pending Feb 29, 2024
18566367 CAS9 NICKASE-MEDIATED GENE EDITING UNIVERSITY OF MASSACHUSETTS NICOL, ALEXANDER W 1634 §103 Non-Final OA 34d Pending Dec 01, 2023
18520821 CONTROLLING PRESSURE Emulate, Inc. SINES, BRIAN J 1796 §103 Non-Final OA 55d Pending Nov 28, 2023
18500793 GLOBAL PROTEOMIC SCREENING OF RANDOM BEAD ARRAYS USING MASS SPECTROMETRY IMAGING AmberGen, Inc. CHEU, CHANGHWA J 1678 §103 Non-Final OA 29d Pending Nov 02, 2023
18199195 SCAFFOLD LOADING AND DELIVERY SYSTEMS Lyra Therapeutics, Inc. ICET, DANIEL ALLEN 3771 §103 Final Rejection 19d overdue Pending May 18, 2023
18027834 CONTINUOUS INFRARED SPECTROSCOPY SYSTEM AND METHOD Dxcover Limited KIDWELL, KAITLYN ELIZABETH 2877 §103 Non-Final OA 2d overdue Pending Mar 22, 2023
17921027 IMPROVED CAS 12A/NLS MEDIATED THERAPEUTIC GENE EDITING PLATFORMS UNIVERSITY OF MASSACHUSETTS KONOPKA, CATHERINE ANNE 1635 §103 Non-Final OA 16d overdue Pending Oct 24, 2022
17773974 CARDIOPROTECTIVE MICROBUBBLE-LIPOSOMAL DRUG COMPLEXES UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION SOROUSH, ALI 1614 §112 Final Rejection 10d overdue Pending May 03, 2022
17639428 DISCERNING BRAIN CANCER TYPE Dxcover Limited MACFARLANE, STACEY NEE 1675 §112 Non-Final OA 11d overdue Pending Mar 01, 2022
17635632 ACOUSTO-THERMAL SHIFT ASSAY FOR LABEL-FREE PROTEIN ANALYSIS The Regents Of The University Of Colorado - A Body Corporate FRITCHMAN, REBECCA M 1758 §103 Final Rejection 66d overdue Pending Feb 15, 2022
17394854 COMPOSITIONS AND METHODS FOR PREVENTING AND/OR INHIBITING VIRAL INFECTION AND SPREAD Peter G. Carroll MARTINEZ, TARA L 1654 §112 Final Rejection 98d overdue Pending Aug 05, 2021
17113516 Scaffold Loading and Delivery Systems Lyra Therapeutics, Inc. ICET, DANIEL ALLEN 3771 §103 Non-Final OA 12d Pending Dec 07, 2020

Managing Medlen & Carroll, LLP's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month